Show simple item record

 
dc.contributorHospital Universitari de Girona Dr Josep Trueta
dc.contributor.authorCosta, Carolina
dc.contributor.authorMerino-Ribas, Ana
dc.contributor.authorFerreira, Ana Catarina
dc.contributor.authorCampos, Carla
dc.contributor.authorSilva, Nádia
dc.contributor.authorPereira, Luciano
dc.date.accessioned2022-01-31T14:07:13Z
dc.date.available2022-01-31T14:07:13Z
dc.date.issued2021-12-14
dc.identifier.citationCosta C, Merino-Ribas A, Ferreira C, Campos C, Silva N, Pereira L, et al. Characterization of Oral Enterobacteriaceae Prevalence and Resistance Profile in Chronic Kidney Disease Patients Undergoing Peritoneal Dialysis. Front Microbiol. 2021 Dec 14;12:736685.
dc.identifier.issn1664-302X
dc.identifier.urihttps://hdl.handle.net/11351/6942
dc.descriptionEnterobacteriaceae; Chronic renal failure; Peritoneal dialysis
dc.description.abstractChronic Kidney Disease (CKD) is a growing public-health concern worldwide. Patients exhibit compromised immunity and are more prone to infection than other populations. Therefore, oral colonization by clinically relevant members of the Enterobacteriaceae family, major agents of both nosocomial and dialysis-associated infections with frequent prevalence of antibiotic resistances, may constitute a serious risk. Thus, this study aimed to assess the occurrence of clinically relevant enterobacteria and their antibiotic resistance profiles in the oral cavity of CKD patients undergoing peritoneal dialysis (CKD-PD) and compare it to healthy controls. Saliva samples from all the participants were cultured on MacConkey Agar and evaluated regarding the levels of urea, ammonia, and pH. Bacterial isolates were identified and characterized for antibiotic resistance phenotype and genotype. The results showed that CKD-PD patients exhibited significantly higher salivary pH, urea, and ammonia levels than controls, that was accompanied by higher prevalence and diversity of oral enterobacteria. Out of all the species isolated, only the prevalence of Raoultella ornithinolytica varied significantly between groups, colonizing the oral cavity of approximately 30% of CKD-PD patients while absent from controls. Antibiotic resistance phenotyping revealed mostly putative intrinsic resistance phenotypes (to amoxicillin, ticarcillin, and cephalothin), and resistance to sulfamethoxazole (~43% of isolates) and streptomycin (~17%). However, all isolates were resistant to at least one of the antibiotics tested and multidrug resistance isolates were only found in CKD-PD group (31,6%). Mobile genetic elements and resistance genes were detected in isolates of the species Raoultella ornithinolytica, Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, and Enterobacter asburiae, mostly originated from CKD-PD patients. PD-related infection history revealed that Enterobacteriaceae were responsible for ~8% of peritonitis and ~ 16% of exit-site infections episodes in CKD-PD patients, although no association was found to oral enterobacteria colonization at the time of sampling. The results suggest that the CKD-induced alterations of the oral milieu might promote a dysbiosis of the commensal oral microbiome, namely the proliferation of clinically relevant Enterobacteriaceae potentially harboring acquired antibiotic resistance genes. This study highlights the importance of the oral cavity as a reservoir for pathobionts and antibiotic resistances in CKD patients undergoing peritoneal dialysis.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Microbiology;12
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectEnterobacteriàcies
dc.subjectInsuficiència renal crònica
dc.subjectDiàlisi peritoneal
dc.subject.meshEnterobacteriaceae
dc.subject.meshRenal Insufficiency, Chronic
dc.subject.meshPeritoneal Dialysis
dc.titleCharacterization of Oral Enterobacteriaceae Prevalence and Resistance Profile in Chronic Kidney Disease Patients Undergoing Peritoneal Dialysis
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fmicb.2021.736685
dc.subject.decsEnterobacteriaceae
dc.subject.decsdiálisis peritoneal
dc.subject.decsinsuficiencia renal
dc.relation.publishversionhttps://doi.org/10.3389/fmicb.2021.736685
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Costa C] Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal. Nephrology & Infectious Diseases R&D Group, INEB - Instituto de Engenharia Biomédica, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. [Merino-Ribas A] Nephrology & Infectious Diseases R&D Group, INEB - Instituto de Engenharia Biomédica, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. Servei de Nefrologia Hospital Universitari de Girona Dr. Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. [Ferreira C] Universidade Católica Portuguesa, CBQF - Centro de Biotecnologia e Química Fina - Laboratório Associado, Escola Superior de Biotecnologia, Porto, Portugal. [Campos C] Instituto Português de Oncologia do Porto Francisco Gentil (IPO), Porto, Portugal. [Silva N] Nephrology Department, Centro Hospitalar Universitário de São João, Porto, Portugal. [Pereira L] Nephrology & Infectious Diseases R&D Group, INEB - Instituto de Engenharia Biomédica, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. Nephrology Department, Centro Hospitalar Universitário de São João, Porto, Portugal
dc.identifier.pmid34970231
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record